Currently, there are 148.15M common shares owned by the public and among those 145.34M shares have been available to trade.
The company’s stock has a 5-day price change of 3.98% and 3.00% over the past three months. ZION shares are trading 19.69% year to date (YTD), with the 12-month market performance up to 75.27% higher. It has a 12-month low price of $28.90 and touched a high of $53.32 over the same period. ZION has an average intraday trading volume of 1.56 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 8.49%, 10.21%, and 19.15% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Zions Bancorporation N.A (NASDAQ: ZION) shares accounts for 78.87% of the company’s 148.15M shares outstanding.
It has a market capitalization of $7.76B and a beta (3y monthly) value of 1.08. The stock’s trailing 12-month PE ratio is 11.96, while the earnings-per-share (ttm) stands at $4.39. The company has a PEG of 2.01 and the debt-to-equity ratio at 0.54. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.75% over the week and 2.65% over the month.
Earnings per share for the fiscal year are expected to increase by 10.75%, and 0.79% over the next financial year. EPS should grow at an annualized rate of 5.96% over the next five years, compared to 1.26% over the past 5-year period.
Looking at the support for the ZION, a number of firms have released research notes about the stock. Morgan Stanley stated their Equal-Weight rating for the stock in a research note on September 30, 2024, with the firm’s price target at $54. Deutsche Bank was of a view on April 10, 2024 that the stock is Hold, while Truist gave the stock Hold rating on January 05, 2024, issuing a price target of $51- $46. Robert W. Baird on their part issued Neutral rating on December 15, 2023.
